Patent Assignment
Reel/Frame 018207/0396
Assignment of Assignor's Interest
Recorded: 2006-09-07
Pages: 10
Assignor
ARDENT PHARMACEUTICAL, INC.
Executed: 2006-08-11
Assignee
MOUNT COOK BIOSCIENCES, INC.
787 7TH AVENUE, 48TH FLOOR, NEW YORK, NEW YORK, 10019
Covered Properties
(30)
Opioid Compounds
Application:
08/098,333 →
Opioid Compounds
Application:
08/169,879 →
Opioid Diarylmethylpiperazines and Piperidines
Patent:
5,658,908 →
Application:
08/284,445 →
Opioid Compounds
Patent:
5,681,830 →
Application:
08/285,313 →
Opioid Compounds and Methods for Making Therefor
Patent:
5,574,159 →
Application:
08/430,677 →
Opioid Compounds and Methods for Using Same
Patent:
5,552,404 →
Application:
08/431,377 →
Compositions and Methods for Reducing Respiratory Depression
Patent:
5,807,858 →
Application:
08/658,726 →
Opioid Diarylmethylpiperazines and Piperidines
Patent:
5,854,249 →
Application:
08/864,667 →
Compositions and Methods for Reducing Respitory Depression and Attendant Side Affects of Mu Opioid Compounds
Patent:
5,985,880 →
Application:
08/887,312 →
Methods for Reducing Respiratory Depression and Attendant Side Effects of Mu Opioid Compounds
Patent:
6,300,332 →
Application:
09/352,308 →
Diarylmethylbenzylpiperazines and corresponding halobenzyl derivatives
Application:
09/957,903 →
Publication:
US 2002/0052007
Compositions and Methods for Reducing Respiratory Depression and Attendant Side Effects of Mu Opioid Compounds
Enantiomerically Pure Opioid Diarylmethylpiperzine and Methods of Using Same
Method of Treating Depression with Delta Receptor Agonist Compounds
Method of Treating Sexual Dysfunctions with Delta Opioid Receptor Agonist Compounds
Method for screening therapeutic agents for modulation of ejaculatory response
Application:
10/335,834 →
Publication:
US 2003/0130698
Compositions and Methods for Combating Lower Urinary Tract Dysfunctions with Delta Opioid Receptor Agonists
Cardioprotective Delta Opioid Receptor Agonists and Methods of Using Same
Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds
Application:
11/184,762 →
Publication:
US 2005/0255151
Enantiomerically Pure Opioid Diarylmethylpiperazine as a Cardioprotection Agent
Compositions of Novel Opioid Compounds and Method of Use Thereof
DPI-125 thiophene analog
Application:
60/324,712 →
Method of treating depression with delta receptor agonist compounds
Application:
60/337,887 →
Method of treating depression with delta receptor agonist compounds
Application:
60/340,084 →
Method for screening therapeutic agents for modulation of ejaculatory response
Application:
60/345,215 →
Method of treating sexual dysfunctions with delta opioid receptor agonist compounds
Application:
60/345,216 →
Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
Application:
60/379,186 →
Cardioprotective delta opioid receptor agonists and method of using same
Application:
60/437,728 →
Compositions of novel opioid compounds and method of use thereof
Application:
60/671,367 →
Method of treating parkinson's disease with a diarylmethylpiperazine compound exhibiting delta receptor agonist activity
Application:
60/714,187 →
Related Assignments
(15)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 12, 1996
From: WELLCOME FOUNDATION LTD., THE; GLAXO WELLCOME HOUSE
To: DELTA PHARMACEUTICALS, INC.
Reel/Frame 008152/0082 →
Assignment of Assignor's Interest
Sep 21, 2001
From: CHANG, KWEN-JEN; PENDERGAST, WILLIAM; BICIUMAS, KESTUTIS P.; WU, EDWIN SHEN-CHOU
To: ARDENT PHARMACEUTICALS, INC.
Reel/Frame 012194/0594 →
Assignment of Assignor's Interest
Jan 23, 2002
From: CHANG, KWEN-JEN; PENDERGAST, WILLIAM; GENGO, PETER J.
To: ARDENT PHARMACEUTICALS, INC.
Reel/Frame 012505/0318 →
Assignment of Assignor's Interest
Nov 3, 2003
From: CHANG, KWEN-JEN; GENGO, PETER J.; BICIUNAS, KESTUTIS P.; MA, XIN
To: ARDENT PHARMACEUTICALS, INC.
Reel/Frame 014650/0016 →
Assignment of Assignor's Interest
Feb 25, 2004
From: CHANG, KWEN-JEN; PENDERGAST, WILLIAM; GENGO, PETER J.; MA, XIN
To: ARDENT PHARMACEUTICALS, INC.
Reel/Frame 015012/0100 →
Assignment of Assignor's Interest
Sep 9, 2005
From: CHANG, KWEN-JEN
To: ARDENT PHARMACEUTICLAS, INC.
Reel/Frame 016767/0229 →
Assignment of Assignor's Interest
Nov 9, 2009
From: MT. COOK PHARMA, INC.
To: ENTHALPY ANALYTICAL, INC.
Reel/Frame 023486/0174 →
Equitable Lien
Feb 17, 2010
From: MT. COOK PHARMA, INC. (PREVIOUSLY DOING BUSINESS AS MOUNT COOK BIOSCIENCES, INC.)
To: VERSI, EBRAHIM
Reel/Frame 023957/0442 →
Assignment of Assignor's Interest
Apr 23, 2010
From: ENTHALPY ANALYTICAL, INC.
To: ENTA HOLDING LLC
Reel/Frame 024278/0419 →
Sale of Assets
Jun 28, 2011
From: MT COOK PHARMA, INC.
To: VERSI, EBRAHIM
Reel/Frame 026511/0230 →
Change of Name
Mar 26, 2012
From: MOUNT COOK BIOSCIENCES, INC.
To: MT. COOK PHARMA, INC.
Reel/Frame 027930/0493 →
Assignment of Assignor's Interest
May 10, 2012
From: VERSI, EBRAHIM
To: VERSI GROUP, LLC
Reel/Frame 028186/0765 →
Assignment of Liens
May 21, 2013
From: ENTHALPY ANALYTICAL, INC. AND ENTA HOLDING LLC
To: VERSI GROUP, LLC
Reel/Frame 030453/0956 →
Assignment of Assignor's Interest
May 26, 2023
From: VERSI GROUP LLC
To: DMK PHARMACEUTICALS CORPORATION
Reel/Frame 063773/0672 →
Assignment of Assignor's Interest
Jun 9, 2023
From: DMK PHARMACEUTICALS CORPORATION
To: DMK PHARMACEUTICALS CORPORATION
Reel/Frame 063903/0246 →